Please provide your email address to receive an email when new articles are posted on . Triptans and dihydroergotamine were not found to cause ischemic vascular events when used in the treatment of ...
The analysis included 64 randomized clinical trials with a total of 46,442 patients. Newer migraine pharmacotherapies appear to be less effective than triptans, according to findings from a systematic ...
October 24, 2006 — Overuse of ergotamine, but not overuse of triptans, increases the risk for ischemia in patients with migraines, according to the results of a retrospective, nested, case-control ...
Migraine, a severe, throbbing pain, usually on one side of the head, is the leading cause of disability in girls and women aged 15 to 49 years. — TNS Some triptans are a more effective treatment for ...
Please provide your email address to receive an email when new articles are posted on . Researchers analyzed 3,119,517 migraine attacks among 36,840 unique medication entries for 278,006 users.
Compared with triptan nonresponders, patients with migraine who report a response to at least 1 triptan have a higher likelihood of responding to treatment with erenumab, according to real-world data ...
Washington, DC — Patients with migraine do not take their prescribed triptan medications in more than two in every five attacks, a new study finds. Results from the largest-ever study to track ...
Triptan use may be associated with a low increased risk for cerebral events, such as stroke, among older adults. Older adults prescribed second-generation serotonin 5HT1B/1D-receptor agonists ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Triptans are a group of drugs targeted at alleviating symptoms of migraine, a severe and often debilitating headache that can affect sight and speech. The triptans available in Australia are: ...
Oct. 11 (UPI) --A class of drugs called triptans remains the most effective treatment for migraines, an analysis of data from more than 60 studies published Monday by JAMA Network Open found. Adults ...
The most effective triptans should be promoted globally and guidelines updated accordingly, say researchers. Some triptans are a more effective treatment for acute migraines than newer, more expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results